CIPLA Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,901
9,543
14,537
14,898
21,040
Total Accounts Receivable
16,903
21,507
27,539
29,114
34,732
Inventories
28,953
37,806
39,887
35,809
42,339
Other Current Assets
5,757
7,059
6,449
7,535
10,031
Total Current Assets
56,514
75,914
88,412
87,356
108,141
Net Property, Plant & Equipment
43,496
46,754
54,888
59,238
59,124
Total Investments and Advances
4,341
2,832
1,991
1,889
2,495
Long-Term Note Receivable
1,480
1,544
600
622
673
Intangible Assets
25,887
27,351
60,833
54,453
51,028
Other Assets
15,197
18,412
3,771
5,131
5,268
Total Assets
147,931
173,835
211,282
210,371
228,606
ST Debt & Current Portion LT Debt
9,300
13,941
49,800
4,673
4,359
Accounts Payable
10,185
16,263
14,841
15,711
21,191
Income Tax Payable
-
375
136
240
31
Other Current Liabilities
6,151
8,357
12,983
13,113
12,741
Total Current Liabilities
25,636
38,936
77,761
33,737
38,322
Long-Term Debt
3,179
3,093
2,219
36,454
36,621
Provision for Risks & Charges
774
1,604
1,447
1,405
1,379
Deferred Taxes
3,090
2,846
8,970
5,888
3,157
Other Liabilities
13,238
16,509
1,266
1,247
1,278
Total Liabilities
46,932
64,015
92,450
80,411
82,634
Common Equity (Total)
100,504
108,015
115,162
125,437
142,292
Total Shareholders' Equity
100,504
108,015
115,162
125,437
142,292
Total Equity
100,999
109,820
118,663
129,819
145,816
Liabilities & Shareholders' Equity
147,931
173,835
211,282
210,371
228,606
Accumulated Minority Interest
496
1,805
3,501
4,382
3,524
Non-Equity Reserves
-
-
169
141
155

About CIPLA

View Profile
Address
Cipla House, Peninsula Business Park
Mumbai Maharashtra 400013
India
Employees -
Website http://www.cipla.com
Updated 09/14/2018
Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the Pharmaceuticals and New Ventures segments. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients.